跳至主要内容
临床试验/EUCTR2018-003537-15-AT
EUCTR2018-003537-15-AT进行中(未招募)1 期

Different dosing of Tranexamic Acid in patients undergoing elective total hip or knee arthroplasty. A randomized, controlled, double-blinded clinical trial.

Medical University Vienna0 个研究点目标入组 180 人开始时间: 2019年1月16日最近更新:
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
180

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

入选标准

  • Undergoing elective total hip or knee arthroplasty under general anaesthesia
  • Age = 18 years
  • Written informed consent given
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range

排除标准

  • Allergy to Tranexamic Acid
  • Acute venous or arterial thrombosis (eg. myocardial infarction, stroke) within the past six months
  • Renal impairment (eGFR <60?ml/min/1.73?m2)
  • Untreated or not sufficient treatable convulsions
  • Patient not able to understand study procedures

研究者

发起方
Medical University Vienna

相似试验